The Union health ministry today banned the manufacture and sale of a drug called letrozole to treat infertility in women, four years after its own drug regulators had waived safety studies and relaxed rules to approve the medicine. In a statement notifying the ban, the ministry said the drug “is likely to involve risk to human beings and safer alternatives are available”. The drug has been used to treat breast cancer in...
More »SEARCH RESULT
Total Matching Records found : 501
Medicines: For Saving Life or For Superprofits? by Bharat Dogra
Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...
More »Bitter pill for Big Pharma by Bhupesh Bhandari
A committee headed by Planning Commission member Arun Maira, the former head of The Boston Consulting Group in India, wants all acquisitions of Indian Pharmaceutical companies by foreigners to be scanned by the Competition Commission of India or CCI. The report will now be sent to Prime Minister Manmohan Singh and Planning Commission Deputy Chairman Montek Singh Ahluwalia. Prime Minister Singh is expected to take a final view on the...
More »Affordable medicine
-The Business Standard It appears a committee headed by Planning Commission member Arun Maira examining the case for continued unrestricted foreign direct investment (FDI) in the pharmaceutical industry has opted to oppose the move to change the present regime. The only concession it is willing to make to the health and commerce ministries’ demand that approval of such investment be routed through the Foreign Investment Promotion Board is to ask for...
More »Expert group moots a new national health regulatory authority by Aarti Dhar
A report by an expert group on Universal Health Coverage (UHC) has suggested wide-ranging institutional reforms to regulate the public and the private sectors to ensure assured quality and rational pricing of healthcare services. The group, set up by the Planning Commission to develop a blue print and investment plan to meet the human resource requirements to achieve health for all by 2020, focuses on rational use of drugs. The extensive...
More »
